Artal Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,001,360
Closed -$20.7M 71
2024
Q2
$20.7M Hold
1,001,360
0.53% 25
2024
Q1
$24.8M Buy
1,001,360
+500,000
+100% +$14.9M 0.63% 23
2023
Q4
$18.2M Buy
+501,360
New +$19.3M 0.61% 24
2023
Q2
Sell
-2,746
Closed -$133K 129
2023
Q1
$133K Buy
+2,746
New +$145K 0.01% 113
2020
Q4
Sell
-351,500
Closed -$3.51M 149
2020
Q3
$3.51M Sell
351,500
-18,500
-5% -$223K 0.09% 109
2020
Q2
$3.87M Buy
370,000
+70,000
+23% +$778K 0.11% 112
2020
Q1
$3.21M Hold
300,000
0.14% 88
2019
Q4
$4.75M Buy
+300,000
New +$3.22M 0.18% 75

Other funds holding PRTA

Artal Group's PRTA Position: Q3 2024 in Review

Artal Group sold out of Prothena Corp (PRTA) in Q3 2024, closing a stake of 1,001,360 shares — an estimated $20.7M sold.

Artal Group first reported a position in PRTA in Q4 2019 and held it in 8 quarters. The position peaked at $24.8M in Q1 2024. 164 funds tracked by Wall St. Rank hold PRTA as of Q3 2024.

  • Artal Group reported no remaining Prothena Corp position as of Q3 2024 after selling out during the quarter.
  • Artal Group sold 1,001,360 Prothena Corp shares in Q3 2024, an estimated $20.7M.
  • Artal Group first reported a position in Prothena Corp in Q4 2019 and held it in 8 quarters.
  • Artal Group's Prothena Corp position peaked at $24.8M in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.